Filing Details

Accession Number:
0000899243-22-015325
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-21 18:04:37
Reporting Period:
2022-04-19
Accepted Time:
2022-04-21 18:04:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1693011 Inozyme Pharma Inc. INZY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253886 G Patrick Enright 2740 Sand Hill Rd 2Nd Floor
Menlo Park CA 94025
No No Yes No
1431159 Juliet Bakker Tammenoms 2740 Sand Hill Road, 2Nd Floor
Menlo Park CA 94025
No No Yes No
1674099 Longitude Venture Partners Iii, L.p. 2740 Sand Hill Rd 2Nd Floor
Menlo Park CA 94025
No No Yes No
1713663 Longitude Capital Partners Iii, Llc 2740 Sand Hill Road
Second Floor
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-19 1,355,000 $3.69 4,174,379 No 4 P Indirect By Longitude Venture Partners III, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Longitude Venture Partners III, L.P.
Footnotes
  1. These shares are held by Longitude Venture Partners III, L.P. ("LVP III"). Longitude Capital Partners III, LLC ("LCP III") is the general partner of LVP III and may be deemed to have voting and dispositive power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and dispositive power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.